ArticleEnvironmental health and preventive medicine2026
Sperm DNA methylation alterations induced by gestational arsenic exposure are established stepwise during spermatogenesis.
Article in Environmental health and preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGestational exposure to environmental toxicants has been reported to be associated with epigenetic alterations in the male germ line. We have previously demonstrated that gestational arsenic exposure induces characteristic DNA methylation alterations in F1 sperm, namely the global DNA hypomethylation and the retrotransposon-associated alterations, including an increased frequency of differentially methylated cytosines (DMCs) and a predominance of hypomethylated DMCs (hypoDMCs) within long terminal repeats (LTRs) and long interspersed nuclear elements (LINEs). Hypomethylation of retrotransposon promoters is associated with increased detrimental retrotransposition and may contribute to disease development. Determining when and how these methylation alterations occur during spermatogenesis is important for elucidating the underlying molecular mechanisms.
methodsTo determine the developmental stage at which these alterations are established, prospermatogonia and type A spermatogonia were isolated from late-gestation and early postnatal testes of F1 male mice exposed to arsenic during gestation. Genome-wide DNA methylation profiles were analyzed in each cell population using reduced representation bisulfite sequencing (RRBS). Global methylation levels and the genomic distribution of DMCs, with particular focus on retrotransposon-associated regions, were examined. In addition, the expression of genes encoding DNA methylation-related enzymes was measured.
resultsGlobal DNA hypomethylation was observed in prospermatogonia derived from arsenic-exposed mice and was also detected in type A spermatogonia. In contrast, an increased frequency of DMCs and a predominance of hypoDMCs within retrotransposon-associated regions were not observed in prospermatogonia or type A spermatogonia, suggesting that these locus-specific alterations may be established during later stages of spermatogenic differentiation subsequent to the type A spermatogonial stage. Furthermore, decreased expression of Dnmt and Tet family genes was observed in prospermatogonia from the arsenic-exposed group.
conclusionsThese findings demonstrate that sperm DNA methylation alterations induced by gestational arsenic exposure are established in a stepwise manner during spermatogenesis. Global DNA hypomethylation associated with alterations in epigenetic remodeling processes is established at the prospermatogonial stage. Subsequently, more locus-specific alterations, characterized by an increased frequency of DMCs and a predominance of hypoDMCs primarily within LTR and LINE retrotransposon regions, emerge during later stages of spermatogenic differentiation subsequent to the type A spermatogonial stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.